The heritage British brand has been revived by a chairman whose impressive career before watchmaking includes a three-year ...

Vertex Pharmaceuticals' unchanged guidance and disappointing trial outcomes for its investigative pain relief treatment led ...

Vertex Pharmaceuticals' Seaport headquarters buildings have been refinanced for $1 billion, putting a ten-figure value on an ...

Vertex Pharmaceuticals ( VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically ...

Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational results for the second quarter ...

A federal judge ruled Hampton’s Zoning Board had ample evidence to reject the tower, but left one legal claim standing.

Vertex Pharmaceuticals Incorporated's stock drop is overblown. With strong CF revenue, pipeline potential, & insider ...

Vertex Pharmaceuticals’ second quarter 2025 results exceeded Wall Street’s expectations, but the market responded sharply ...

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...

Vertex Corp. (5290.TO) Japan 1st Quarter Ended June 30 GROUP 2025 2024 Revenue Y8.70 bln Y8.24 bln Operating Profit Y1.08 bln Y781.00 mln Pretax Profit Y1.15 bln Y830.00 mln Net Profit Y658.00 mln ...

ELIVAAS plans to utilise the funds to expand its presence in India, increase operations in high-demand leisure and business ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.